Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot
Code deleted, see 80361, 80362, 80363, 80364

Official Description

Opiate(s), drug and metabolites, each procedure

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

Opiates are a class of drugs that include both natural opioid alkaloids and semisynthetic compounds, which are derived from opium poppy or synthesized in laboratories. Common examples of opiates include morphine, meperidine (known by the brand name Demerol), hydrocodone, hydromorphone, codeine, oxycodone, and oxymorphone. These substances are primarily utilized in the medical field to manage moderate to severe acute or chronic pain, providing significant relief for patients suffering from various pain conditions. However, due to their pharmacological properties, opiates also carry a risk of abuse and dependency, making their monitoring crucial in clinical settings. The CPT® Code 83925 specifically refers to the testing of opiates and their metabolites, which is essential for assessing the presence and concentration of these substances in a patient's system. This testing is particularly important for evaluating potential toxicity levels, monitoring therapeutic use, and identifying possible cases of substance abuse. The most common specimen type collected for opiate testing is urine, as it is non-invasive and provides reliable results. However, other specimen types such as blood and meconium stool may also be utilized depending on the clinical scenario. In urine testing, various methodologies such as chromatography and immunoassay are employed to detect the presence of opiate drugs or their metabolites. For meconium specimens, quantitative liquid chromatography-tandem mass spectrometry is typically used to provide accurate measurements of opiate levels. Similarly, serum or plasma samples can be analyzed using quantitative liquid chromatography-tandem mass spectrometry or other chromatographic techniques to ensure comprehensive assessment of opiate presence in the body.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

Testing for opiates and their metabolites is indicated in several clinical scenarios, including:

  • Monitoring Therapeutic Use This test is performed to ensure that patients receiving opiate medications for pain management are adhering to their prescribed treatment regimens and to assess the effectiveness of the therapy.
  • Assessing Toxicity Levels The test is utilized to evaluate the toxicity of opiates in patients who may have overdosed or are experiencing adverse effects from opiate use.
  • Identifying Substance Abuse Opiate testing is crucial in detecting potential abuse or misuse of opiate medications, particularly in patients with a history of substance use disorders.
  • Legal and Employment Testing Opiate testing may be required in legal situations or as part of employment screening processes to ensure compliance with drug-free workplace policies.

2. Procedure

The procedure for testing opiates and their metabolites involves several key steps, which are outlined below:

  • Specimen Collection The first step in the procedure is the collection of a biological specimen, which is most commonly urine. However, blood or meconium stool specimens may also be collected based on the clinical requirements. Proper collection techniques must be followed to avoid contamination and ensure accurate results.
  • Preparation of the Specimen Once the specimen is collected, it may need to be prepared for analysis. This can involve processes such as centrifugation for blood samples to separate plasma or serum, or dilution of urine samples to meet testing requirements.
  • Testing Methodology The prepared specimen is then subjected to testing using various methodologies. For urine samples, immunoassay techniques may be employed for initial screening, followed by confirmatory testing using chromatography methods. In the case of meconium, quantitative liquid chromatography-tandem mass spectrometry is typically utilized to accurately measure opiate levels.
  • Result Interpretation After testing, the results are interpreted by qualified personnel. This includes determining the presence and concentration of opiates and their metabolites, which is essential for making clinical decisions regarding patient care.

3. Post-Procedure

Post-procedure care primarily involves the communication of test results to the appropriate healthcare providers. If the test indicates the presence of opiates, further evaluation may be necessary to determine the clinical significance of the findings. This could include additional testing, adjustments to pain management strategies, or referrals to substance abuse treatment programs if misuse is suspected. Patients may also require counseling or education regarding the risks associated with opiate use, especially if they are prescribed these medications for pain management. Continuous monitoring and follow-up testing may be recommended to ensure patient safety and compliance with treatment protocols.

Short Descr ASSAY OF OPIATES
Medium Descr OPIATE(S) DRUG AND METABOLITES EACH PROCEDURE
Long Descr Opiate(s), drug and metabolites, each procedure
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 9 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Items and Services Packaged into APC Rates
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE Not applicable/unspecified.
CCS Clinical Classification 206 - Microscopic examination (bacterial smear, culture, toxicology)
Date
Action
Notes
2015-01-01 Deleted Code deleted, see 80361, 80362, 80363, 80364
2009-01-01 Changed Code description changed
2008-01-01 Changed Code description changed.
1993-01-01 Added First appearance in code book in 1993.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"